News & Perspective

Oct 11, 2017

Oct 11, 2017
Ebola vaccine study

Liberia trial finds Ebola vaccines yield year-long immune response

A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.

Jul 06, 2017

Jul 06, 2017
Chemical testing

WHO: Cofactor suspected in Liberian meningitis cluster

The cluster has been classified as a meningococcal C outbreak, but a cofactor may be involved.

May 19, 2017

May 19, 2017
Ebola treatment center

WHO: 9 more Ebola cases in DRC, 29 total

Though global risk remains low, 7 countries have begun screening at airports and ports of entry.

May 08, 2017

May 08, 2017
Neisseria meningitidis

Meningitis suspected in Liberia's mystery illness outbreak

Liberian official says meningitis is the possible cause of puzzling cases.

May 01, 2017

May 01, 2017
Eye dropper

Liberia illness cluster grows as officials await toxicology results

Analysis of 3 urine specimens finds no common pattern.

Apr 28, 2017

Apr 28, 2017
polio vaccine supplies

WHO vaccine advisors weigh in on polio, cholera, Ebola, diphtheria

Experts made more recommendations about fractional IPV dosing and also discussed issued related to cholera, Ebola, and diphtheria.

Apr 26, 2017

Apr 26, 2017
Liberia map

Ebola ruled out in unexplained Liberian deaths

A WHO official said the hospital cluster involves 17 illnesses, 9 of them fatal, and specimens from 6 people who died tested negative for Ebola.

Apr 06, 2017

Apr 06, 2017
Ebola vaccine trial

Large trial launches of different Ebola vaccine strategies

The phase 2 trials will enroll more than 5,000 adults and kids in Guinea and Liberia.

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Apr 06, 2016

Apr 06, 2016
White House

White House to shift Ebola funds for Zika response

The Obama administration, though, is sticking with its $1.9 billion request, some of which would cover the shift.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»